Charter Research & Investment Group’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.67M | Sell |
23,680
-575
| -2% | -$43K | 1.12% | 23 |
|
|
2025
Q4 | $1.91M | Buy |
24,255
+125
| +0.5% | +$9.89K | 1.28% | 23 |
|
|
2025
Q3 | $1.99M | Hold |
24,130
| – | – | 1.38% | 19 |
|
|
2025
Q2 | $1.94M | Sell |
24,130
-533
| -2% | -$41.1K | 1.45% | 21 |
|
|
2025
Q1 | $1.98M | Hold |
24,663
| – | – | 1.51% | 20 |
|
|
2024
Q4 | $2.02M | Sell |
24,663
-200
| -0.8% | -$16.6K | 1.54% | 20 |
|
|
2024
Q3 | $2.05M | Sell |
24,863
-300
| -1% | -$22.4K | 1.51% | 20 |
|
|
2024
Q2 | $1.77M | Sell |
25,163
-250
| -1% | -$17.9K | 1.39% | 22 |
|
|
2024
Q1 | $1.88M | Sell |
25,413
-59
| -0.2% | -$4.11K | 1.49% | 23 |
|
|
2023
Q4 | $1.68M | Buy |
25,472
+965
| +4% | +$60.4K | 1.4% | 22 |
|
|
2023
Q3 | $1.54M | Sell |
24,507
-445
| -2% | -$27.7K | 1.39% | 22 |
|
|
2023
Q2 | $1.41M | Sell |
24,952
-1,056
| -4% | -$58.6K | 1.17% | 26 |
|
|
2023
Q1 | $1.51M | Hold |
26,008
| – | – | 1.32% | 25 |
|
|
2022
Q4 | $1.88M | Sell |
26,008
-145
| -0.6% | -$10.4K | 1.81% | 17 |
|
|
2022
Q3 | $1.59M | Sell |
26,153
-190
| -0.7% | -$12.1K | 1.61% | 20 |
|
|
2022
Q2 | $1.65M | Buy |
26,343
+675
| +3% | +$44.7K | 1.5% | 22 |
|
|
2022
Q1 | $1.8M | Sell |
25,668
-165
| -0.6% | -$11.2K | 1.46% | 24 |
|
|
2021
Q4 | $1.61M | Buy |
25,833
+1,320
| +5% | +$82.8K | 1.27% | 27 |
|
|
2021
Q3 | $1.51M | Sell |
24,513
-335
| -1% | -$20.2K | 1.26% | 30 |
|
|
2021
Q2 | $1.49M | Hold |
24,848
| – | – | 1.23% | 30 |
|
|
2021
Q1 | $1.51M | Sell |
24,848
-625
| -2% | -$34.5K | 1.32% | 28 |
|
|
2020
Q4 | $1.2M | Hold |
25,473
| – | – | 1.15% | 29 |
|
|
2020
Q3 | $947K | Sell |
25,473
-1,225
| -5% | -$46.5K | 1.04% | 29 |
|
|
2020
Q2 | $975K | Sell |
26,698
-700
| -3% | -$24.4K | 1.12% | 29 |
|
|
2020
Q1 | $838K | Sell |
27,398
-1,850
| -6% | -$82K | 1.1% | 30 |
|
|
2019
Q4 | $1.49M | Hold |
29,248
| – | – | 1.52% | 23 |
|
|
2019
Q3 | $1.38M | Sell |
29,248
-450
| -2% | -$21.5K | 1.49% | 24 |
|
|
2019
Q2 | $1.48M | Sell |
29,698
-890
| -3% | -$41.8K | 1.64% | 25 |
|
|
2019
Q1 | $1.3M | Sell |
30,588
-50
| -0.2% | -$2.21K | 1.44% | 29 |
|
|
2018
Q4 | $1.26M | Sell |
30,638
-525
| -2% | -$22.5K | 1.59% | 26 |
|
|
2018
Q3 | $1.46M | Sell |
31,163
-365
| -1% | -$16.7K | 1.59% | 24 |
|
|
2018
Q2 | $1.38M | Hold |
31,528
| – | – | 1.58% | 27 |
|
|
2018
Q1 | $1.45M | Hold |
31,528
| – | – | 1.73% | 25 |
|
|
2017
Q4 | $1.59M | Buy |
+31,528
| New | +$1.66M | 1.79% | 25 |
|
|
2016
Q3 | $1.34M | Sell |
33,804
-10,114
| -23% | -$380K | 1.57% | 26 |
|
|
2016
Q2 | $1.56M | Buy |
43,918
+892
| +2% | +$34.8K | 1.78% | 24 |
|
|
2016
Q1 | $1.69M | Sell |
43,026
-1,201
| -3% | -$44.9K | 1.93% | 23 |
|
|
2015
Q4 | $1.9M | Buy |
44,227
+11,742
| +36% | +$516K | 2.21% | 18 |
|
|
2015
Q3 | $1.36M | Sell |
32,485
-10,351
| -24% | -$484K | 1.8% | 23 |
|
|
2015
Q2 | $2.14M | Sell |
42,836
-95
| -0.2% | -$4.5K | 2.37% | 17 |
|
|
2015
Q1 | $1.93M | Sell |
42,931
-275
| -0.6% | -$12.4K | 2.14% | 21 |
|
|
2014
Q4 | $2.08M | Buy |
+43,206
| New | +$2.05M | 2.28% | 20 |
|
Other funds holding MET
VCM
VPM
Charter Research & Investment Group's MET Position: Q1 2026 in Review
Charter Research & Investment Group reduced its MetLife (MET) stake by 2.4% in Q1 2026, selling an estimated $43K and leaving 23,680 shares worth $1.67M. The position accounts for 1.12% of the portfolio, ranked #23.
Charter Research & Investment Group first reported a position in MET in Q4 2014 and has held it in 42 quarters since. The position peaked at $2.14M in Q2 2015. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Charter Research & Investment Group held 23,680 shares of MetLife worth $1.67M as of Q1 2026.
- Charter Research & Investment Group sold 575 MetLife shares in Q1 2026, an estimated $43K.
- MetLife made up 1.12% of Charter Research & Investment Group's portfolio in Q1 2026, its #23 holding.
- Charter Research & Investment Group first reported a position in MetLife in Q4 2014 and has held it in 42 quarters since.
- Charter Research & Investment Group's MetLife position peaked at $2.14M in Q2 2015.
- 1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Charter Research & Investment Group's 13F filing for Q1 2026, filed 12 May 2026.